Researchers study use of dasatinib for patients with high-risk MDS

The therapy may not be effective for all patients, but those with trisomy 8 chromosomal disorder have higher rates of stable disease and respond better to treatment with dasatinib, the study shows.

http://www.sciencedaily.com/releases/2013/03/130321105107.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fpharmacology+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Pharmacology%29